GENEVA, March 25 -- SANA BIOTECHNOLOLGY, INC. (188 East Blaine StreetSuite 400Seattle, Washington 98102) filed a patent application (PCT/US2025/045442) for "IMMUNOSUPPRESSION RESISTANT T CELLS FOR POST-TRANSPLANT DISORDERS" on Sep 09, 2025. With publication no. WO/2026/059868, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SCHREPFER, Sonja (c/o SANA BIOTECHNOLOGY, INC.188 East Blaine Street, Suite 400Seattle, 98102)

Abstract: The present disclosure provides engineered T cells with reduced expression or knock out of an i...